Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine in Root Canal Treatment of Necrotic Mature Teeth With Apical Periodontitis
NCT07262554Phase 2Active, not recruiting
- Sponsor
- Alexandria University
- Start
- Nov 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of acetylcysteine in apical periodontitis (AP) (2 arms), sponsored by Alexandria University. Primary endpoints: Postoperative pain intensity at 1 week and Assessment of periapical healing at 6 months. Started Nov 2025; status: active, not recruiting.
02
Drugs
acetylcysteine
03
Conditions
apical periodontitis (AP)
Beyond the preview
Go deeper on NCT07262554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07262554.